Adenosine A2A Receptor-Antagonist/Dopamine D2 Receptor-Agonist Bivalent Ligands as Pharmacological Tools to Detect A2A-D2 Receptor Heteromers | Journal of Medicinal Chemistry
κ-opioid receptor - Wikipedia
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
Frontiers | The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics | Hypertension
Frontiers | The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
The receptor hypothesis and the pathogenesis of depression: Genetic bases and biological correlates - ScienceDirect
Direct Selection of DNA-Encoded Libraries for Biased Agonists of GPCRs on Live Cells | JACS Au
Opioid antagonists are associated with a reduction in the symptoms of schizophrenia: a meta-analysis of controlled trials | Neuropsychopharmacology
I'll Be Back”: The Resurrection of Dezocine | ACS Medicinal Chemistry Letters
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
Frontiers | The role of endogenous opioid neuropeptides in neurostimulation-driven analgesia
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
Frontiers | The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
Advances in the Treatment of Chronic Pain by Targeting GPCRs | Biochemistry
![Standard Opioid Agonists Activate Heteromeric Opioid Receptors: Evidence for Morphine and [d-Ala2-MePhe4-Glyol5]Enkephalin as Selective μ−δ Agonists | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/cn9000236/asset/images/medium/cn-2009-000236_0007.gif "Standard Opioid Agonists Activate Heteromeric Opioid Receptors: Evidence for Morphine and [d-Ala2-MePhe4-Glyol5]Enkephalin as Selective μ−δ Agonists | ACS Chemical Neuroscience")
Standard Opioid Agonists Activate Heteromeric Opioid Receptors: Evidence for Morphine and [d-Ala2-MePhe4-Glyol5]Enkephalin as Selective μ−δ Agonists | ACS Chemical Neuroscience
Frontiers | The Signaling and Pharmacology of the Dopamine D1 Receptor
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Biomedicines | Free Full-Text | Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity
Molecular mechanism of biased signaling at the kappa opioid receptor | Nature Communications
Dynorphin-kappa opioid receptor activity in the central amygdala modulates binge-like alcohol drinking in mice | Neuropsychopharmacology
